Veracyte (VCYT) Cash from Investing Activities Growth (1y) (2013 - 2026)
Veracyte (VCYT) Cash from Investing Activities Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 465.38% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -1,600.38% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -2.89% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -13.29% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -91.12% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 32.46% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 35.74% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -480.95% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -353.86% |
| 10 | Veracyte | 4.76 Bn | 4.50 Bn | 101.16 Mn | -146.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146.94% |
| Dec 31, 2025 | 89.97% |
| Sep 30, 2025 | 2,252.68% |
| Jun 30, 2025 | 91.91% |
| Mar 31, 2025 | -1,900.49% |
| Dec 31, 2024 | -2,068.24% |
| Sep 30, 2024 | 19.99% |
| Jun 30, 2024 | 24.50% |
| Mar 31, 2024 | -88.05% |
| Dec 31, 2023 | 90.55% |
| Sep 30, 2023 | -131.82% |
| Jun 30, 2023 | 60.58% |
| Mar 31, 2023 | 1,081.66% |
| Dec 31, 2022 | -6,965.97% |
| Sep 30, 2022 | 105.32% |
| Jun 30, 2022 | -731.84% |
| Mar 31, 2022 | 99.57% |
| Dec 31, 2021 | 143.36% |
| Sep 30, 2021 | -10,019.69% |
| Jun 30, 2021 | 326.96% |